Insulin resistance and metabolic syndrome in first-degree relatives of patients with type 2 diabetes mellitus;Resistencia a la insulina y sindrome metabolico en familiares de primer grado de pacientes con diabetes mellitus tipo 2

Medicina Clinica

Volumn 112, Issue 8, 1999, Pages 281-284

  Camps, Isabel ^a   Biarnés, Josefina ^b   Fernández Real, José Manuel ^b   Insa, Roser ^d   Soler, Juan ^d   Fernández Castañer, Miguel ^c  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SYNDROME DELINEATION;

EID: 0033528458     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1.595-1.607.
2. Ferranini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
3. Lillioja S, Mott DM, Sparaul M, Ferraro R, Foley JE, Ravussin E et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 1.988-1.992.
4. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113: 909-915.
5. Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states. J Clin Invest 1994; 94: 1.714-1.721.
6. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 1996; 39: 1.201-1.207.
7. Generalitat de Catalunya. Departament de Sanitat i Seguretat Social. Pla de Salut de Catalunya, 1993-1995. Barcelona: Departament de Sanitat i Seguretat Social, 1993; 249-251.
8. Helmrich SP, Ragland RD, Leung RW, Paffenbarger RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991; 325: 147-152.
9. Knowler WC, Narayan KMV. Prevention of non-insulin-dependent diabetes mellitus. Preventive Medicine 1994; 23: 701-703.
10. Bourn DM, Mann JI, McSkimming BJ, Waldron MA, Wishart JD. Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect? Diabetes Care 1994; 17: 1.311-1.319.
11. Camps I. Perspectives terapèutiques i prevenció en la diabetes mellitus tipus 2. En: Fernández Álvarez J, Fernández-Castañer M, Del Pozo i Picó C, Simo i Canonge R, Úbeda i Arbesuk J, editores. Diabetes mellitus. Associacio Catalana de Diabetis. Barcelona: Edicions El Mèdol, 1996.
12. Kobberling J, Tillil H. Empirical risk figures for fisrt degree relatives of non-insulin-dependent diabetics. En: Kobberling J, Tattersall R, editores. The genetics of diabetes mellitus. Londres: Academic Press 1982; 201-209.
13. Fernández-Castañer M, Biarnés J, Camps I, Ripollés J, Gómez N, Soler J. Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Diabetic Med 1996; 13: 953-959.
14. Pimenta W, Mitrakou A, Jensen T, Yki-Jarvinen H, Daily G, Gerich J. Insulin secretion and insulin sensitivity in peoples with impaired glucose tolerance. Diabetic Med 1996; 13 (Supl): 33-36.
15. Humphriss DB, Stewart MW, Berrish TS, Barriocanal LA, Trajano LR, Ashworth LA et al. Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families. Diabetologia 1997; 40: 1.185-1.190.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
17. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 1.183-1.197.
18. Hodge AM, Zimmet PZ. The epidemiology of obesity. Bailliere's Clin Endocrinol Metab 1994; 8: 577-599.
19. The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Bethesda. MD: National Institutes of Health, National Heart. Lung and Blood Institute, 1993.
20. Betteridge DJ, Khan M. Review of new guidelines for management of dyslipidemia. Bailliere's Clin Endocrinol Metab 1995; 9: 867-890.
21. SPSS Inc., editor. SPSS-X Users Guide. Nueva York. NY: McGraw-Hill Book Company, 1983.
22. Perseghin G, Ghosh S, Gerow K, Shulman GI. Metabolic defects in lean nondiabetic offspring of NIDDM parents. A cross-sectional study. Diabetes 1997; 46: 1.001-1.009.
23. World Health Organization. Diabetes mellitus: report of a WHO expert committee on diabetes mellitus. Tech Rep Ser, n. 646. Ginebra: World Health Organization, 1985.
24. Mooy JM, Gooethenhuis PA, De Vries H, Kostense PJ, Popp-Snijders C, Coulter LM et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in general Caucasian population: the Hoorn study. Diabetologia 1996; 39: 298-305.
25. Castell C, Goday A, Lloveras G. Epidemiología de la diabetes mellitus. En: Fernández Álvarez J, Fernández-Castañer M, Del Pozo Picó C, Simó Canonge R, Úbeda Arbesuk J. editores. Diabetis mellitus. Barcelona: Associació Catalana de Diabetis, 1996.
26. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Comparison of diabetes diagnostic categories in the US population according to 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 1997; 20: 1.859-1.862.
27. Fernández-Castañer M. Nuevos criterios de diagnóstico y clasificación de la diabetes mellitus [editorial]. Endocrinologia (Barc) 1998; 45: 107-110.
28. Laws A, Stefanick ML, Reaven GM. Insulin resistance and hypertriglyceridemia in non diabetic relatives of patients with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1989; 69: 343-347.
29. Ericksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widén E, Schallin C et al. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 1989; 321: 337-343.
30. Gulli G, Ferranmi E, Stern M, Haffner S, DeFronzo R. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two mexican-american NIDDM parents. Diabetes 1992; 41: 1.575-1.586.
31. Stewart MW, Humphriss DB, Berrish TS, Barriocanal LA, Trajano LR, Alberti KGMM et al. Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care 1995; 18: 1.020-1.022.
32. Haffner SM, González C, Miettinen H, Kennedy E, Stern MP. A prospective analysis of the HOMA model. The Mexico city diabetes study. Diabetes Care 1996; 19: 1.138-1.141.
33. Porte DJ. Beta-cells in type II diabetes mellitus. Diabetes 1992; 40: 166-189.
34. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabetic Med 1993; 10: 313-320.
35. Birkeland KI, Torjesen PA, Eriksson J, Vaaler S, Groop L. Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia. Diabetes Care 1994; 17: 1.307-1.310.
36. Biarnés J, Fernández-Castañer M, Camps I, Ripollés J, Soler J. Proinsulin secretion in non diabetic first-degree relatives of NIDDM patients [resumen]. Diabetologia 1996; 39 (Supl 1); 148.